The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 685-690

  Gindzienska Sieskiewicz, Ewa ^a   Klimiuk, Piotr Adrian ^a   Kisiel, Dariusz Gabriel ^a   Gindzienski, Andrzej ^a   Sierakowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Galactosylation; Immunoglobulin G; Rheumatoid arthritis

Indexed keywords

CARBOHYDRATE; GALACTOSE; IMMUNOGLOBULIN G; MANNOSE; MONOSACCHARIDE; OLIGOSACCHARIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENZYME GLYCOSYLATION; ENZYME ISOLATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIODIAGNOSIS; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; GALACTOSE; HUMANS; IMMUNOGLOBULIN G; JOINTS; MIDDLE AGED; MONOSACCHARIDES;

EID: 34147151811     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0370-7     Document Type: Article

References (32)

1. Mackiewicz S, Hrycaj P (1995) Rheumatoid arthritis. In: Mackiewics S, Zimmermann-Gorska I (eds) Reumatologia, PZWL, Warsaw pp 87-101
2. Berger E (1996) How are oligosaccharides synthesized? Eur J Biochem 25-27
3. Watson M, Rudd PM, Bland M, Dwek RA, Axford J (1999) Sugar printing rheumatic diseases. A potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 42:1682-1690
4. Palamarczyk G (1987) Heterogennocæ struktury reszt cukrowych N-glikoprotein jako wynik procesów kotranslacyjnych. Post Bioch 33:297-307
5. Alavi A, Arden N, Spector TD, Axford JS (2000) Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 27:1379-1385
6. Bond A, Alavi A, Axford JS, Bourke BE, Brukner FE, Kerr MA, Maxwell JD, Youinou P, Hay FC (1997) A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetyloglucosoamine. J Autoimmun 10:77-85
7. Dwek RA (1995) Glycobiology: More functions for oligosaccharides. Science 269:1234-1235
8. Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, Roitt IM (1992) Changes in normal glycosylation mechanism in autoimmune rheumatic disease. J Clin Invest 89:1021-1031
9. Bond A, Alavi A, Axford JS, Youinou P, Hay FC (1996) The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis, juvenile chronic arthritis and Sjögren's syndrome. Clin Exp Immunol 105:99-103
10. Tomana M, Schrohenloher RE, Koopman WJ, Alarcon GS, Paul WA (1998) Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31:418-419
11. Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM (1987) Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 26:1186-1192
12. Axford JS (1997) The importance of oligosaccharides to rheumatic disease: A personal perspective. Glycoconj J 14:863-866
13. Dwek R (1995) Glycobiology: More functions for oligosaccharides. Science 269:1234-1235
14. Dwek RA (1996) Glycobiology: Towards understanding the function of sugars. Chem Rev 96:638-720
15. Klama K, Lacki JK, Müller W, Mackiewicz SH (1996) The abnormalities in the glycosylation of IgG. Reumatologia 34:26-30
16. Madhok R, Cappell HA (1988) Galactose residues in chronic inflammatory disease (letter). Lancet 8582:418
17. Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM (1988) Galactose residues in chronic inflammatory (reply). Lancet 8582:418
18. Lucey MD, Newkirk BM, Roitt IM, Dwek RA, Rademacher TW (2000) Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 27:319-323
19. Parekh RB, Isenberg DA, Ansell BM, Roitt IM, Dwek RA, Rademacher TW (1988) Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. The Lancet 1(8592):966-969 (April 30)
20. Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: An aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425-1429
21. Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W (1996) Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med 28:265-269
22. Tsuchiya N, Endo T, Shiota M, Kochibe N, Ito N, Kobata A (1994) Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis. Clin Immunol Immunopathol 70:47-50
23. Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845-1850
24. Saha SK, Brewer CF (1994) Determination of the concentration of oligosaccharides, complex type carbohydrates and glycoproteins using the phenolsulfuric acid method. Carbohydr Res 254:157-167
25. Tang W, Matsumoto A, Shikata K, Takeuchi F, Konishi T, Nakata M, Mizuochi T (1998) Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis. Glycoconj J 15:929-934
26. Leader KA, Lastra GC, Kirwan JR, Elson CJ (1996) Agalactosyl IgG in aggregates from the rheumatoid joints. Br J Rheumatol 35:335-341
27. Soltys AJ, Hay FC, Bond A, Oxford JS, Jonem MG, Randek I, Thompson KM, Natvig JB (1994) The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 40:135-143
28. Van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, Ghelani S, Rademacher TW, Breedveld FC (1994) Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: Results of follow-up study. Br J Rheumatol 3:36-43
29. Bond A, Sumar N, Bodman K, Colacos CB, Young A, Hay FC (1994) Relationship of IgG glycosylation, soluble IL-2 receptors and IL-6 to disease activity in rheumatoid arthritis. Br J Rheumatol 33:992-993
30. Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA (1997) Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36:1370-1380
31. Krotkiewski H (1999) Carbohydrate moiety of immunoglobulins in health and pathology. Acta Biochim Pol 46:341-350
32. Youings A, Chang SC, Dwek RA, Scragg IG (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J 314:621-630